Alpa Laboratorie

  • Market Cap: Micro Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE385I01010
  • NSEID: ALPA
  • BSEID: 532878
INR
60.00
-0.57 (-0.94%)
BSENSE

Sep 16, 11:20 AM

BSE+NSE Vol: 12.51 k

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
{
  "main_header": {
    "sid": 476646,
    "name": "Alpa Laboratorie",
    "stock_name": "Alpa Laboratorie",
    "full_name": "Alpa Laboratories Ltd",
    "name_url": "stocks-analysis/alpa-laboratorie",
    "exchange": 0,
    "exchangecode": "",
    "primexch": 1,
    "country_id": 34,
    "currency": "INR",
    "cmp": "60.00",
    "chg": -0.57,
    "chgp": "-0.94%",
    "dir": -1,
    "prev_price": "60.57",
    "mcapval": "126.24 Cr",
    "mcap": "Micro Cap",
    "scripcode": 532878,
    "symbol": "ALPA",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 4,
    "sector_id": 65,
    "indexname": "India SENSEX",
    "isin": "INE385I01010",
    "curr_date": "Sep 16, 11:20 AM",
    "curr_time": "11:23 AM",
    "last_traded_at": "Sep 16, 11:20 AM IST",
    "bse_nse_vol": "12.51 k",
    "exc_status": "Active",
    "traded_date": "Sep 16, 2026",
    "traded_date_str": "2026 09 16",
    "score": "",
    "scoreText": "",
    "Live": 1,
    "market_time": 1,
    "is_blur": 1,
    "is_blur_class": "blur-register-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/alpa-laboratorie-476646-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [
      {
        "title": "Alpa Laboratories Ltd is Rated Strong Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/alpa-laboratories-ltd-is-rated-strong-sell-4195026",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/9/AlpaLaboratorie_mojoScore_4195026.png",
        "date": "2026-09-16 10:10:19",
        "description": "Alpa Laboratories Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 14 August 2026. However, the analysis and financial metrics discussed here reflect the stock’s current position as of 16 September 2026, providing investors with the latest insights into its performance and outlook."
      },
      {
        "title": "Alpa Laboratories Ltd is Rated Strong Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/alpa-laboratories-ltd-is-rated-strong-sell-4177772",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/9/AlpaLaboratorie_mojoScore_4177772.png",
        "date": "2026-09-01 10:10:26",
        "description": "Alpa Laboratories Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 14 August 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 01 September 2026, providing investors with an up-to-date view of the company’s fundamentals, returns, and market standing."
      },
      {
        "title": "Alpa Laboratories Ltd is Rated Strong Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/alpa-laboratories-ltd-is-rated-strong-sell-4163957",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/8/AlpaLaboratorie_mojoScore_4163957.png",
        "date": "2026-08-21 10:10:24",
        "description": "Alpa Laboratories Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 14 August 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 21 August 2026, providing investors with an up-to-date view of the company’s fundamentals, returns, and market standing."
      },
      {
        "title": "Alpa Laboratories Ltd Valuation Shifts Signal Elevated Risk Amid Sector Challenges",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/alpa-laboratories-ltd-valuation-shifts-signal-elevated-risk-amid-sector-challenges-4156935",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/8/AlpaLaboratorie_valuationdot_4156935.png",
        "date": "2026-08-17 08:00:56",
        "description": "Alpa Laboratories Ltd, a micro-cap player in the Pharmaceuticals & Biotechnology sector, has seen its valuation parameters deteriorate significantly, prompting a downgrade to a Strong Sell rating. With its price-to-earnings (P/E) ratio rising to 32.77 and price-to-book value (P/BV) at 0.71, the stock now appears riskier compared to its historical averages and peer group, reflecting growing investor caution amid underwhelming returns and sector headwinds."
      },
      {
        "title": "Are Alpa Laboratories Ltd latest results good or bad?",
        "link": "https://www.marketsmojo.com/news/result-analysis/are-alpa-laboratories-ltd-latest-results-good-or-bad-4154715",
        "imagepath": "",
        "date": "2026-08-14 19:50:26",
        "description": "Alpa Laboratories Ltd's latest financial results for Q4 FY26 present a complex picture characterized by contrasting trends in profitability and revenue performance. The company reported a net profit of ₹1.38 crore, which reflects a sequential decline of 13.21% compared to the previous quarter. In terms of revenue, Alpa Laboratories generated ₹31.40 crore, marking an 8.09% increase from Q3 FY26 but a significant year-on-year decline of 21.34% from ₹39.92 crore in Q4 FY25. This revenue contraction is noteworthy as it follows a period of strong growth in the prior year, indicating potential challenges in sustaining sales momentum.\n\nDespite the revenue decline, the operating margin improved to 11.46%, the highest level in seven quarters, suggesting that the company has made strides in cost management. However, this margin expansion appears to be primarily driven by cost rationalization rather than an increase i..."
      },
      {
        "title": "Alpa Laboratories Ltd Reports Sharp Decline in Quarterly Financial Performance Amid Negative Trend Shift",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/alpa-laboratories-ltd-reports-sharp-decline-in-quarterly-financial-performance-amid-negative-trend-shift-4153652",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/8/AlpaLaboratorie_fintrenddot_4153652.png",
        "date": "2026-08-14 11:00:11",
        "description": "Alpa Laboratories Ltd, a micro-cap player in the Pharmaceuticals & Biotechnology sector, has reported a significant deterioration in its recent quarterly financial performance. The company’s latest results for June 2026 reveal a marked decline in revenue, profitability, and key return metrics, signalling a shift from a previously flat to a negative financial trend. This downturn comes amid broader sector pressures and contrasts sharply with benchmark indices such as the Sensex."
      },
      {
        "title": "Alpa Laboratories Ltd is Rated Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/alpa-laboratories-ltd-is-rated-sell-4145264",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/8/AlpaLaboratorie_mojoScore_4145264.png",
        "date": "2026-08-10 10:10:03",
        "description": "Alpa Laboratories Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 30 May 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 10 August 2026, providing investors with an up-to-date view of the company’s performance and outlook."
      },
      {
        "title": "When is the next results date for Alpa Laboratories Ltd?",
        "link": "https://www.marketsmojo.com/news/result-analysis/when-is-the-next-results-date-for-alpa-laboratories-ltd-4138681",
        "imagepath": "",
        "date": "2026-08-05 23:19:06",
        "description": "The next results date for Alpa Laboratories Ltd is scheduled for 14 August 2026...."
      },
      {
        "title": "Alpa Laboratories Ltd is Rated Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/alpa-laboratories-ltd-is-rated-sell-4128581",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/7/AlpaLaboratorie_mojoScore_4128581.png",
        "date": "2026-07-30 10:10:03",
        "description": "Alpa Laboratories Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 30 May 2026. While the rating change occurred on that date, the analysis and financial metrics discussed here reflect the stock's current position as of 30 July 2026, providing investors with an up-to-date perspective on the company’s performance and outlook."
      }
    ],
    "total": 129,
    "sid": "476646",
    "stock_news_url": "https://www.marketsmojo.com/news/alpa-laboratories-476646"
  },
  "announcements": [
    {
      "caption": "Announcement under Regulation 30 (LODR)-Change in Management",
      "datetime": "07-Sep-2026",
      "details": "Appointment of Mrs. Radhika Biyani as an Independent Director.",
      "source": "BSE"
    },
    {
      "caption": "Fixes Book Closure For The Purpose Of AGM.",
      "datetime": "07-Sep-2026",
      "details": "Intimation of Book Closure for the Purpose of 38th AGM.",
      "source": "BSE"
    },
    {
      "caption": "Reg. 34 (1) Annual Report.",
      "datetime": "07-Sep-2026",
      "details": "Annual Report for the Financial Year Ended March 312026",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "No <strong>Dividend</strong> history available",
      "data": []
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "No <strong>Splits</strong> history available",
      "data": []
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}
stock newsNews and Views
stock-recommendationAnnouncement

Announcement under Regulation 30 (LODR)-Change in Management

07-Sep-2026 | Source : BSE

Appointment of Mrs. Radhika Biyani as an Independent Director.

Fixes Book Closure For The Purpose Of AGM.

07-Sep-2026 | Source : BSE

Intimation of Book Closure for the Purpose of 38th AGM.

Reg. 34 (1) Annual Report.

07-Sep-2026 | Source : BSE

Annual Report for the Financial Year Ended March 312026

stock-recommendationCorporate Actions
Corporate Actions
info
stock-summary
BOARD MEETING

No Upcoming Board Meetings

stock-summary
DIVIDEND

No Dividend history available

stock-summary
SPLITS

No Splits history available

stock-summary
BONUS

No Bonus history available

stock-summary
RIGHTS

No Rights history available